The systemic inflammation indexes predict all-cause mortality in peritoneal dialysis patients

References

• Li PK, Chow KM. Peritoneal dialysis-first policy made successful: perspectives and actions. Am J Kidney Dis. 2013;62(5):993–1005.
   PubMed Web of Science ®Google Scholar
• Saran R, Li Y, Robinson B, et al. US renal data system 2014 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2015;66(Supp11):S1–S305.
   PubMedGoogle Scholar
• Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42(5):864–881.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Humphreys MH, et al. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1507–1519.
   PubMed Web of Science ®Google Scholar
• Li PK, Ng JK, Mcintyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017;37(1):54–65.
   PubMed Web of Science ®Google Scholar
• Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31(2):159–171.
   PubMed Web of Science ®Google Scholar
• Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14(7):1871–1879.
   PubMed Web of Science ®Google Scholar
• Zhang W, He J, Zhang F, et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J Nephrol. 2013;26(2):243–253.
   PubMed Web of Science ®Google Scholar
• Lu X, Wang S, Zhang G, et al. High neutrophil-to-lymphocyte ratio is a significant predictor of cardiovascular and All-Cause mortality in patients undergoing peritoneal dialysis. Kidney Blood Press Res. 2018;43(2):490–499.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang M, Zhao Q, et al. Platelet-to-lymphocyte ratio is associated with the mortality in peritoneal dialysis patients. Iran J Kidney Dis. 2021;15(3):206–212.
   PubMed Web of Science ®Google Scholar
• Wen Y, Zhan X, Wang N, et al. Monocyte/lymphocyte ratio and cardiovascular disease mortality in peritoneal dialysis patients. Mediators Inflamm. 2020;2020:9852507.
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Zou Y, et al. Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail. 2022;44(1):1227–1235.
   PubMed Web of Science ®Google Scholar
• Fois AG, Paliogiannis P, Scano V, et al. The systemic inflammation index on admission predicts in-Hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725.
   PubMed Web of Science ®Google Scholar
• Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173–182.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Chen Z, Chen Q, et al. Neutrophil to lymphocyte ratio predicts adverse cardiovascular outcome in peritoneal dialysis patients younger than 60 years old. Mediators Inflamm. 2020;2020:4634736.
   PubMed Web of Science ®Google Scholar
• Chen T, Yang M. Platelet-to-lymphocyte ratio is associated with cardiovascular disease in continuous ambulatory peritoneal dialysis patients. Int Immunopharmacol. 2020;78:106063.
   PubMed Web of Science ®Google Scholar
• Paliogiannis P, Ginesu GC, Tanda C, et al. Inflammatory cell indexes as preoperative predictors of hospital stay in open elective thoracic surgery. ANZ J Surg. 2018;88(6):616–620.
   PubMed Web of Science ®Google Scholar
• Jomrich G, Gruber ES, Winkler D, et al. Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020;24(3):610–618.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu X, Xiao L, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421–427.
   PubMed Web of Science ®Google Scholar
• Sun L, Hu W, Liu M, et al. High systemic inflammation response index (SIRI) indicates poor outcome in gallbladder cancer patients with surgical resection: a single institution experience in China. Cancer Res Treat. 2020;52(4):1199–1210.
   PubMed Web of Science ®Google Scholar
• Bronze-da-Rocha E, Santos-Silva A. Neutrophil elastase inhibitors and chronic kidney disease. Int J Biol Sci. 2018;14(10):1343–1360.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Nagasaki M, Kunishima S, et al. IL-1α induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol. 2015;209(3):453–466.
   PubMed Web of Science ®Google Scholar
• Cognasse F, Duchez AC, Audoux E, et al. Platelets as key factors in inflammation: focus on CD40L/CD40. Front Immunol. 2022;13:825892.
   PubMed Web of Science ®Google Scholar
• Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957–976.
   PubMed Web of Science ®Google Scholar
• Kim Y, Choi H, Jung SM, et al. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology. 2019;24(7):711–717.
   PubMed Web of Science ®Google Scholar
• Chen JB, Tang R, Zhong Y, et al. Systemic immune-inflammation index predicts a reduced risk of end-stage renal disease in Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective observational study. Exp Ther Med. 2021;22(3):989.
   PubMed Web of Science ®Google Scholar
• Basu N, Karabayas M, Pusey C. Prognosis and future developments in vasculitis. Best Pract Res Clin Rheumatol. 2018;32(1):148–165.
   PubMed Web of Science ®Google Scholar
• Halpern SE, Moris D, Shaw BI, et al. The systemic immune-inflammation index predicts clinical outcomes in kidney transplant recipients. In Vivo. 2020;34(6):3349–3360.
   PubMed Web of Science ®Google Scholar
• Chen MQ, Wang HY, Shi WR, et al. Estimate of prevalent hyperuricemia by systemic inflammation response index: results from a rural Chinese population. Postgrad Med. 2021;133(2):242–249.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Bakris GL, Borghi C, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the national kidney foundation. Am J Kidney Dis. 2018;71(6):851–865.
   PubMed Web of Science ®Google Scholar